All In Biotech

Drug Trial Radar · NCT00000271

New Approaches to Cocaine Abuse Medications (A) - 6

New Approaches to Cocaine Abuse Medications (A)

Last checked: Nov 20, 2026Latest source record: Jul 5, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 111 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

111

Actual

Start

Jan 1995

Primary completion

Oct 2002

Study completion Oct 2002

Sponsor

Lead sponsor
New York State Psychiatric InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Drug Abuse (NIDA)
First posted
Sep 21, 1999

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure the effect of desipramine in cocaine abusers selected for major depression or dysthymia.

Conditions

  • Cocaine-Related Disorders
  • Substance-Related Disorders

Interventions

  • DesipramineDrug

    Participants were treated with desipramine, up to 300 mg per day, or matching placebo. All participants received weekly individual manual-guided relapse prevention therapy.

  • PlaceboDrug

    Participants were treated with matching placebo. All participants received weekly individual manual-guided relapse prevention therapy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cocaine UseTime frame: Weekly over a 12 week period.
  2. DepressionTime frame: Bi-weekly over a 12 week period.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Foundation for Mental Hygiene

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.